Biomarin Pharmaceutical (BMRN)

Add to Watchlists Create an Alert
69.38 +1.17  +1.72% NASDAQ Sep 18, 3:49PM BATS Real time Currency in USD
View Full Chart
BMRN Price Chart
View All Events

BMRN Events

Date Type Description
07/30/2014 16:30 EDT Misc Q2 2014 Biomarin Earnings Conference Call
07/30/2014 Earnings Q2 2014 Biomarin Earnings Results
05/01/2014 17:00 EDT Misc Q1 2014 Biomarin Earnings Conference Call
05/01/2014 Earnings Q1 2014 Biomarin Earnings Results
03/03/2014 08:00 EST Misc Biomarin Pharmaceutical, Inc. Q4 2013 Earnings Conference Call
03/03/2014 Earnings Biomarin Pharmaceutical, Inc. Q4 2013 Earnings Results
10/24/2013 17:00 EDT Misc BioMarin to Host Third Quarter 2013 Financial Results Conference Call and Webcast
10/24/2013 Earnings BioMarin -Third Quarter 2013 Financial Results
View All Performance Charts

BMRN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biomarin Pharmaceutical is down 8.66% over the last year vs S&P 500 Total Return up 20.45%, Alexion Pharmaceuticals up 40.75%, and Biogen Idec up 36.72%.

Get Quote for

PDF Report for BMRN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download BMRN Pro Report PDF

Portfolio Strategies Featuring BMRN

Did Biomarin Pharmaceutical make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BMRN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website:
  • IR Website:
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Biomarin Pharmaceutical Inc develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its product portfolio is comprised of five product candidates Naglazyme, Kuvan, Aldurazyme, VIMIZIM and Firdapse.

BMRN Excel Add-In Codes

  • Name: =YCI("BMRN","name")
  • Description: =YCI("BMRN","description")
  • Sector: =YCI("BMRN","sector")
  • Industry: =YCI("BMRN","industry")
  • Est. Current Fiscal Year End: =YCI("BMRN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start your {{}} Membership


{{ ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{}} Member? Sign in here.